Product Information

BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Sandoz Inc., priced at $7.4078 per ML under NDC 00781601470. Its NADAC has been published 288 times since May 19, 2021.

FDA first approved this application on Apr 1, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

BRINZOLAMIDE 1% EYE DROPS

Brinzolamide
$7.4078per ML

Strength

10 mg/mL

Manufacturer

Sandoz Inc.

NDC

00781601470

Classification

Generic

Dosage Form

SUSPENSION/ DROPS

Route

OPHTHALMIC

Effective Date

11/18/2026

Active Ingredients

BRINZOLAMIDE

Approval Type

Authorized Generic (NDA)

FDA Application

NDA020816

FDA Approved

4/1/1998

TE Code

AB

On Market Since

3/8/2021

Pharmacological Classes

Carbonic Anhydrase Inhibitor
Carbonic Anhydrase Inhibitors

Price Statistics

The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 288 times since May 19, 2021, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.

Current price$7.4078 per ML
All-time high$26.8459 (Apr 13, 2022)
All-time low$7.4078 (Nov 18, 2026)
52-week high$12.9336
52-week low$7.4078
Median price$14.9723
Average price$16.0317
Largest weekly change+26.9% (Aug 21, 2024)
Weeks tracked288
Tracking sinceMay 19, 2021

Price History

1W

-6.8%

1M

-13.1%

3M

-21.9%

6M

-26.7%

1Y

-39.5%

3Y

-56.2%

5Y

-64.6%

All

-70.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 3%

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?

The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Sandoz Inc., is $7.4078 per ML (NDC 00781601470), effective Nov 18, 2026.

How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?

Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 70.8%. It has been tracked across 288 weekly CMS publications since May 19, 2021.

What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?

Since May 19, 2021, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $7.4078 (Nov 18, 2026) to a high of $26.8459 (Apr 13, 2022), with a median of $14.9723 per ML.

Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $7.1808 per ML — about 3% below BRINZOLAMIDE 1% EYE DROPS.

Who manufactures BRINZOLAMIDE 1% EYE DROPS?

BRINZOLAMIDE 1% EYE DROPS (NDC 00781601470) is labeled by Sandoz Inc., and CMS classifies it as a generic product.